These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22654281)

  • 1. Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.
    Reid S
    Indian J Community Med; 2012 Apr; 37(2):89-94. PubMed ID: 22654281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
    Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
    Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.
    Ali Khan A; Munir M; Miraj F; Imran S; Arif Siddiqi D; Altaf A; Khan AJ; Chandir S
    Hum Vaccin Immunother; 2021 Sep; 17(9):3247-3258. PubMed ID: 33989509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.
    Bahuguna P; Prinja S; Lahariya C; Dhiman RK; Kumar MP; Sharma V; Aggarwal AK; Bhaskar R; De Graeve H; Bekedam H
    Appl Health Econ Health Policy; 2020 Jun; 18(3):393-411. PubMed ID: 31741306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses.
    Kermode M
    Health Promot Int; 2004 Mar; 19(1):95-103. PubMed ID: 14976177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.
    Dziekan G; Chisholm D; Johns B; Rovira J; Hutin YJ
    Bull World Health Organ; 2003; 81(4):277-85. PubMed ID: 12764494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China.
    Murakami H; Kobayashi M; Zhu X; Li Y; Wakai S; Chiba Y
    Soc Sci Med; 2003 Nov; 57(10):1821-32. PubMed ID: 14499508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of unsafe injections.
    Miller MA; Pisani E
    Bull World Health Organ; 1999; 77(10):808-11. PubMed ID: 10593028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.
    Aylward B; Kane M; McNair-Scott R; Hu DJ; Hu DH
    Int J Epidemiol; 1995 Apr; 24(2):446-52. PubMed ID: 7635609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid assessment of injection practices in Cambodia, 2002.
    Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
    BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-benefit analysis on the replacement program of ordinary syringes by auto-disposal syringes in China].
    Shi G; Xie YF; Zhang Y; Liu XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):180-3. PubMed ID: 12816706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection practices in southern part of India.
    Rajasekaran M; Sivagnanam G; Thirumalaikolundusubramainan P; Namasivayam K; Ravindranath C
    Public Health; 2003 May; 117(3):208-13. PubMed ID: 12825472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan?
    Janjua NZ; Mahmood B; Imran Khan M
    J Infect Public Health; 2014; 7(4):345-55. PubMed ID: 24861642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population risk of syringe reuse: estimating the probability of transmitting bloodborne disease.
    Sikora C; Chandran AU; Joffe AM; Johnson D; Johnson M
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):748-54. PubMed ID: 20509761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries-A Cost-Effectiveness Analysis From Egypt.
    Mostafa A; El-Sayed MH; El Kassas M; Elhamamsy M; Elsisi GH
    Value Health Reg Issues; 2019 Sep; 19():51-58. PubMed ID: 31002984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
    Ekwueme DU; Weniger BG; Chen RT
    Bull World Health Organ; 2002; 80(11):859-70. PubMed ID: 12481207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global burden of disease attributable to contaminated injections given in health care settings.
    Hauri AM; Armstrong GL; Hutin YJ
    Int J STD AIDS; 2004 Jan; 15(1):7-16. PubMed ID: 14769164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
    Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
    Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.